Internal Medicine, Endocrinology, Diabetes, & Metabolism · Monroe, NY
NPI
1750607602
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
855 State Route 17m
Monroe, NY, 10950
Phone (845) 703-6999
Groups this clinician bills Medicare through
Medicare paid, 2024
$552K
29,949 services
Medicare patients, 2024
845
Average age 72
Drug cost, 2024
$3.7M
7,823 prescriptions
Company payments, 2025
$250
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas A Avitabile was code J0897 (injection, denosumab, 1 mg), 7,440 times for 79 patients. In total Nicholas A Avitabile billed 29,949 services in 101 codes, and Medicare paid $552K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,440 | 79 | $20.31 | $151K |
| J3262 Injection, tocilizumab, 1 mg | Office | 6,580 | 11 | $4.71 | $31K |
| 99214 Office E&M - Established | Office | 1,182 | 624 | $95.99 | $113K |
| 36415 Venipuncture Blood Collection | Office | 943 | 518 | $8.64 | $8,149 |
| 80053 Clinical Chemistry | Office | 640 | 437 | $10.35 | $6,624 |
| 84443 Clinical Chemistry | Office | 620 | 420 | $16.46 | $10K |
| 85025 Blood Count | Office | 589 | 401 | $7.61 | $4,482 |
| 80061 Clinical Chemistry | Office | 559 | 370 | $13.10 | $7,325 |
| 83036 Blood Count | Office | 523 | 347 | $9.49 | $4,966 |
| 82306 Clinical Chemistry | Office | 408 | 317 | $28.85 | $12K |
| 82607 Clinical Chemistry | Office | 359 | 270 | $14.72 | $5,286 |
| 82570 Clinical Chemistry | Office | 345 | 240 | $5.07 | $1,749 |
| 82043 Clinical Chemistry | Office | 345 | 240 | $5.65 | $1,949 |
| 83735 Clinical Chemistry | Office | 266 | 204 | $6.55 | $1,742 |
| 84439 Clinical Chemistry | Office | 179 | 128 | $8.84 | $1,582 |
By year: 2022 $432K for 21,591 services; 2023 $541K for 31,730 services; 2024 $552K for 29,949 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 943 | 518 | $8.64 | $8,149 |
| 80053 Clinical Chemistry | 640 | 437 | $10.35 | $6,624 |
| 84443 Clinical Chemistry | 620 | 420 | $16.46 | $10K |
| 85025 Blood Count | 589 | 401 | $7.61 | $4,482 |
| 80061 Clinical Chemistry | 559 | 370 | $13.10 | $7,325 |
| 83036 Blood Count | 523 | 347 | $9.49 | $4,966 |
| 82306 Clinical Chemistry | 408 | 317 | $28.85 | $12K |
| 82607 Clinical Chemistry | 359 | 270 | $14.72 | $5,286 |
| 82570 Clinical Chemistry | 345 | 240 | $5.07 | $1,749 |
| 82043 Clinical Chemistry | 345 | 240 | $5.65 | $1,949 |
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas A Avitabile prescribed most often to Medicare patients was Levothyroxine Sodium, with 959 prescriptions and refills. In total Nicholas A Avitabile wrote 7,823 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 959 | 2,221 | 232 | $14K |
| Ozempic Semaglutide | 644 | 927 | 115 | $866K |
| Metformin Hcl Er Metformin Hcl | 484 | 1,344 | 154 | $6,484 |
| Metformin Hcl Generic | 338 | 867 | 98 | $3,560 |
| Mounjaro Tirzepatide | 316 | 350 | 53 | $364K |
| Synthroid Levothyroxine Sodium | 305 | 705 | 67 | $24K |
| Glimepiride Generic | 296 | 739 | 80 | $3,585 |
| Trulicity Dulaglutide | 277 | 387 | 56 | $373K |
| Jardiance Empagliflozin | 241 | 468 | 59 | $272K |
| Atorvastatin Calcium Generic | 208 | 584 | 66 | $2,251 |
| Farxiga Dapagliflozin Propanediol | 180 | 358 | 43 | $198K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 148 | 317 | 52 | $28K |
| Alendronate Sodium Generic | 125 | 337 | 44 | $1,378 |
| Januvia Sitagliptin Phosphate | 116 | 261 | 31 | $143K |
| Lisinopril Generic | 115 | 340 | 38 | $734 |
Brand drugs: 3,826 claims; generic drugs: 3,593 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas A Avitabile $250 ($250 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $250.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 2 | $250 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.